SCHEMBL6022142

SCHEMBL6022142

COc1ccc(N(Cc2ccccc2)S(=O)(=O)c2ccc3c(c2)c(C(F)(F)F)cc(=O)n3C)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 5/20 0.55
ALDH1A1 P00352 3/20 0.55
LMNA P02545 3/20 0.55
PGR P06401 2/20 0.55
NPSR1 Q6W5P4 2/20 0.55
CNR1 P21554 3/20 0.50
CNR2 P34972 3/20 0.50
MMP9 P14780 2/20 0.48
MMP13 P45452 2/20 0.48
CYP3A4 P08684 1/20 0.47
GAA P10253 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
MAPT P10636 1/20 0.46
PTPN1 P18031 1/20 0.45
MMP1 P03956 1/20 0.45
ADAM17 P78536 1/20 0.45
CYP11B1 P15538 1/20 0.44
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6022248 0.82 RXFP1 (0.51) CNR1CNR2MAPTPTPN1MEN1
SCHEMBL6022153 0.80 RXFP1 (0.51) ALDH1A1LMNACNR2GAAMAPT
SCHEMBL6022348 0.77 RXFP1 (0.53) ALDH1A1LMNACNR2GAAMAPT
SCHEMBL6022392 0.77 POLB (0.49) NR3C1PGR
SCHEMBL6022256 0.76 MAPK1 (0.48) ALDH1A1MEN1KMT2A
SCHEMBL5761653 0.75 NR3C1 (0.53) NR3C1ALDH1A1LMNAPGRNPSR1
SCHEMBL5763553 0.75 NR3C1 (0.53) NR3C1ALDH1A1LMNAPGRNPSR1
SCHEMBL6022484 0.71 ALDH1A1 (0.62) ALDH1A1LMNA
SCHEMBL1279470 0.69 PTGES (0.80) NR3C1ALDH1A1LMNAPGRNPSR1
SCHEMBL6022155 0.69 ALDH1A1 (0.54) ALDH1A1LMNACYP3A4GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7009052-B2 Sulfonamide derivatives WARNER LAMBERT COMPANY LLC (US) 2006-03-07 US claimed
US-20050004367-A1 Sulfonamide derivatives DU DANIEL Y (US) 2005-01-06 US claimed
US-7009052-B2 Sulfonamide derivatives WARNER LAMBERT COMPANY LLC (US) 2006-03-07 US disclosed
US-20050004367-A1 Sulfonamide derivatives DU DANIEL Y (US) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004367-A1 Sulfonamide derivatives AR, SULT2A1, SHBG NR3C1 424/4885ALDH1A1 841/4885LMNA 4429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.